R1H

tariquidar

Find entries where: R1H

is present as a standalone ligand in 4 entries

Find related ligands:

Chemical Component Summary
Name	tariquidar
Synonyms	~{N}-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1~{H}-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxy-phenyl]quinoline-3-carboxamide
Identifiers	~{N}-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1~{H}-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxy-phenyl]quinoline-3-carboxamide
Formula	C₃₈ H₃₈ N₄ O₆
Molecular Weight	646.732
Type	NON-POLYMER
Isomeric SMILES	COc1cc2c(cc1OC)CN(CC2)CCc3ccc(cc3)NC(=O)c4cc(c(cc4NC(=O)c5cc6ccccc6nc5)OC)OC
InChI	InChI=1S/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43)
InChIKey	LGGHDPFKSSRQNS-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	86
Chiral Atom Count	0
Bond Count	91
Aromatic Bond Count	29

Drug Info: DrugBank

DrugBank ID	DB06240
Name	Tariquidar
Groups	investigational
Synonyms	Tariquidar
Indication	Investigated for use/treatment in ovarian cancer, lung cancer, and breast cancer.
Categories	Drug Resistance, Multiple Heterocyclic Compounds, Fused-Ring P-glycoprotein inhibitors
CAS number	206873-63-4

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682